Cullinan Therapeutics, Inc. (CGEM) vs Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

A side-by-side comparison of Cullinan Therapeutics, Inc. and Lumexa Imaging Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CGEM vs LMRI

growth of $100 · dividends reinvested · last 1y
CGEM +28.7% (+28.7%/yr)LMRI -41.8% (-41.8%/yr)CGEM compounded faster over this window
50100150Start $1002026$129$58
CGEM LMRI

CGEM vs LMRI: by the numbers

  • •LMRI is the larger company ($1.02B vs $1.00B market cap).
  • •Both run net losses; CGEM's is the smaller (0.00% vs -2.66% net margin).

Metrics side by side

Valuation

MetricCGEMLMRI
Forward P/EN/A16.58
P/S ratioN/A0.98
P/B ratio3.121.66
EV / EBITDAN/A27.98
FCF yieldN/A3.11%

Profitability

MetricCGEMLMRI
Gross margin0.00%11.80%
Operating margin0.00%1.38%
Net margin0.00%-2.66%
ROE-63.62%-4.51%
ROIC-68.64%0.86%

Growth (annualized)

MetricCGEMLMRI
Total return CAGR (5Y)-7.48%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.